Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 661-672 of 1073 results.
">Needle-Free connectors (NFCs) are widely used to access vascular infusion circuits. Despite their safety benefits, NFCs still present risks for colonization and vascular ingress by pathogenic microbes" Truong et al (2025).
"To examine the variation of the operative definition and occurrence of unused peripheral intravenous catheters in pre-hospital and hospital settings, and to describe possible predictors of this phenomenon" Ambrosi et al (2025).
"The findings emphasize the need for targeted educational programs and continuous professional development to address knowledge gaps in CVC-RI prevention. Healthcare institutions should prioritize up-to-date curricula, ongoing training initiatives, and reliable information sources to enhance ICU nurses' ability to prevent catheter-related infections and improve patient care outcomes" Alshammari et al (2025).
"During the 2024 IV fluid shortage, fewer patients received fluids at lower volumes per patient. This held true for discharged patients with GI symptoms. Overall, LOS decreased without an increase in 72-h return rate. Improved throughput without changes in return rate represents a potential process improvement and warrants further evaluation" Stenson et al (2025).
"This aim of this review is to update current evidence on antibiotic stability in elastomeric infusion pumps, analyzing environmental factors, clinical efficacy, and practical challenges associated with OPAT implementation" Moreal et al (2025).
"This study demonstrates the efficacy and safety of our minimally invasive endovascular approach for managing subclavian artery catheter misplacements" Lenhart et al (2025).
"Central line-associated bloodstream infections (CLABSI) are preventable hospital-acquired infections. Predicting CLABSI helps improve early intervention strategies and enhance patient safety" Albu et al (2025).
"In this cohort study of 371 061 PIVCs, dwell time was associated with the development of BSIs with PIVCs. After day 3, PIVC indication should be reviewed and PIVC replacement considered" Zanella et al (2025).
"To improve outcomes, nurses should adhere to evidence-based protocols for maintaining IV patency and proactively educate mothers on recognizing signs of phlebitis" Casman et al (2025).
"The heparin-vancomycin-amikacin combination lock solution was more effective in preventing CRIs than heparin alone in haemodialysis patients” Arabzadeh et al (2025).
"Length of stay increased by an average of 5.2 days for falls, 12.9 days for pressure ulcers, 22.1 days for central line-associated bloodstream infections, and 7.9 days for surgical site infections” Hasan et al (2025).
"Evidence on the safety and cost-effectiveness of IV anti-cancer therapy at home is scarce and outdated. IV anti-cancer regimens have evolved; the findings of studies performed more than a decade ago may lack applicability to current practice. However, key considerations when considering suitability for home treatment remain unchanged: safety, duration of treatment and geographic catchment area” Grobler et al (2025).
